Last reviewed · How we verify

NCT03702127

TMS - Intracranial Electrodes

ENROLLING BY INVITATION NA Last updated 12 June 2025
What this trial tests

NA trial testing Transcranial magnetic stimulation in Epilepsy Intractable in 50 participants. Enrolling by invitation.

Timeline
16 July 2019
Primary endpoint
30 June 2026
30 July 2026

Quick facts

Lead sponsorAaron Boes
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment50
Start date16 July 2019
Primary completion30 June 2026
Estimated completion30 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Aaron Boes

Who can join

18 and older, any sex, with Epilepsy Intractable. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a study looking at the effects of transcranial magnetic stimulation (TMS), a form of non-invasive brain stimulation (NIBS), on the human brain as recorded by intracranial electroencephalography in neurosurgical patients. NIBS will be applied in a targeted manner and brain responses will be recorded.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcranial magnetic stimulation

Trials testing the same drug.

Other recruiting trials for Epilepsy Intractable

Currently open trials in the same condition.

Other Aaron Boes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03702127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing